Clinical Trial of High Dose CoQ10 in ALS
Public ClinicalTrials.gov record NCT00243932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy and preferred dose of CoQ10 in individuals with ALS for a possible future phase III study.
Study identification
- NCT ID
- NCT00243932
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 185 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 21 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2005 (Type not available)
- Primary completion
- Mar 2008 (Actual)
- Completion
- Mar 2008 (Actual)
- Last update posted
- May 7, 2024
2005 – 2008
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas for Medical Sciences, Department of Neurology | Little Rock | Arkansas | 72201 | — |
| California Pacific Medical Center | San Francisco | California | 94101 | — |
| University of California at San Francisco | San Francisco | California | 94101 | — |
| University of Colorado Health Sciences, Dept of Neurology | Denver | Colorado | 80221 | — |
| Yale University School of Medicine, Department of Neurology | New Haven | Connecticut | 06501 | — |
| Northwestern University, Department of Neurology, | Chicago | Illinois | 60290 | — |
| University of Chicago, Department of Neurology | Chicago | Illinois | 60292 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 64116 | — |
| University of Kentucky, Dept of Neurology, College of Medicine | Lexington | Kentucky | 40201 | — |
| Brigham and Women's Hospital , Department of Neurology | Boston | Massachusetts | 02108 | — |
| Baystate Medical Center, Division of Critical Care Research | Springfield | Massachusetts | 01101 | — |
| Minneapolis Medical Research Foundation, , | Minneapolis | Minnesota | 55421 | — |
| Washington University in St. Louis School of Medicine, Department of Neurology | St Louis | Missouri | 63101 | — |
| Columbia Presbyterian Medical Center, The Neurological Institute | New York | New York | 10032 | — |
| State University of New York Upstate Medical, Neurology Department | Syracuse | New York | 13201 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44101 | — |
| Drexel University, Dept of Neurology | Philadelphia | Pennsylvania | 19113 | — |
| University of Texas, Health Science Center at San Antonio, Division of Neurology | San Antonio | Texas | 78201 | — |
| University of Vermont, Neurology Department | Burlington | Vermont | 05401 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00243932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2024 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00243932 live on ClinicalTrials.gov.